These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 30521789)
1. Comparison of electroencephalogram (EEG) response to MDPV versus the hallucinogenic drugs MK-801 and ketamine in rats. Shokry IM; Sinha V; Da Silva G; Park SB; Callanan JJ; Tao R Exp Neurol; 2019 Mar; 313():26-36. PubMed ID: 30521789 [TBL] [Abstract][Full Text] [Related]
6. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines. Kohler RJ; Perrine SA; Baker LE Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316 [TBL] [Abstract][Full Text] [Related]
7. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters. Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092 [TBL] [Abstract][Full Text] [Related]
8. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone. Colon-Perez LM; Pino JA; Saha K; Pompilus M; Kaplitz S; Choudhury N; Jagnarine DA; Geste JR; Levin BA; Wilks I; Setlow B; Bruijnzeel AW; Khoshbouei H; Torres GE; Febo M Neuropharmacology; 2018 Jul; 137():178-193. PubMed ID: 29729891 [TBL] [Abstract][Full Text] [Related]
9. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure. Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275 [TBL] [Abstract][Full Text] [Related]
11. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine. Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596 [TBL] [Abstract][Full Text] [Related]
12. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats. Risca HI; Baker LE Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256 [TBL] [Abstract][Full Text] [Related]
13. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat. Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332 [TBL] [Abstract][Full Text] [Related]
14. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198 [TBL] [Abstract][Full Text] [Related]
15. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. Anneken JH; Angoa-Pérez M; Kuhn DM J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880 [TBL] [Abstract][Full Text] [Related]
16. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects. Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011 [TBL] [Abstract][Full Text] [Related]
17. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160 [TBL] [Abstract][Full Text] [Related]
18. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity. Colon-Perez LM; Tran K; Thompson K; Pace MC; Blum K; Goldberger BA; Gold MS; Bruijnzeel AW; Setlow B; Febo M Neuropsychopharmacology; 2016 Aug; 41(9):2352-65. PubMed ID: 26997298 [TBL] [Abstract][Full Text] [Related]
19. Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV. Steele TWE; Spires Z; Jones CB; Glennon RA; Dukat M; Eltit JM Neuropharmacology; 2021 Dec; 200():108820. PubMed ID: 34619165 [TBL] [Abstract][Full Text] [Related]
20. Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats. Kolanos R; Partilla JS; Baumann MH; Hutsell BA; Banks ML; Negus SS; Glennon RA ACS Chem Neurosci; 2015 May; 6(5):771-7. PubMed ID: 25688761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]